BARCLAYS PLC

Position in NVS — Novartis AG

CIK 312069 LONDON, X0

Back to NVS Full portfolio

Position in NVS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,352,023

+$210,523 QoQ

Shares Held

8,627

+15.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#536

of 1,603 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Derivatives in NVS

reported options exposure · as of Jun 30, 2026

CallValue

CallShares

PutValue

$14,778,696

PutShares

94,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $8,073,972,287 across 18 Drug Manufacturers - General names. NVS ranks #16 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,143,891	$1,372,017,294
2	ABBV	AbbVie Inc.	5,015,515	$1,262,104,193
3	AZN	Astrazeneca PLC	6,592,403	$1,250,051,454
4	JNJ	Johnson & Johnson	4,651,595	$1,181,365,579
5	MRK	Merck & Co., Inc.	6,793,897	$873,015,763
6	GILD	Gilead Sciences, Inc.	5,113,242	$646,006,993
7	AMGN	Amgen Inc	1,326,673	$480,414,824
8	PFE	Pfizer Inc	16,746,801	$403,262,965

All Filings in NVS

Export CSV

42 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$14,778,696	94,300	+36.1%	Put	Defined	2026-08-14
2026-06-30	$1,352,023	8,627	+15.4%	Shares	Defined	2026-08-14
2026-03-31	$1,141,500	7,473	+1727.1%	Shares	Defined	2026-05-15
2026-03-31	$10,585,575	69,300	-41.1%	Put	Defined	2026-05-15
2025-12-31	$56,388	409	-27.4%	Shares	Sole	2026-02-13
2025-12-31	$41,361	300	-99.7%	Call	Sole	2026-02-13
2025-09-30	$72,198	563	-46.9%	Shares	Sole	2026-03-31
2025-06-30	$128,390	1,061	-94.2%	Shares	Defined	2026-02-27
2025-03-31	$2,037,073	18,273	+1290.6%	Shares	Sole	2026-03-17
2024-12-31	$127,863	1,314	-95.2%	Shares	Defined	2026-03-19
2024-09-30	$11,502,000	100,000	+25.5%	Call	Sole	2026-03-31
2024-09-30	$3,180,531	27,652	+1727.6%	Shares	Sole	2026-03-31
2024-09-30	$13,526,352	117,600	+969.1%	Put	Sole	2026-03-31
2024-06-30	$161,072	1,513	+334.8%	Shares	Defined	2026-03-23
2024-06-30	$8,484,862	79,700	-1.2%	Call	Sole	2026-03-23
2024-03-31	$33,661	348	+9.1%	Shares	Sole	2026-03-24
2023-12-31	$32,209	319	-2.7%	Shares	Defined	2026-03-24
2023-09-30	$33,409	328	-97.0%	Shares	Sole	2026-03-26
2023-06-30	$1,107,789	10,978	+1963.5%	Shares	Defined	2026-03-27
2023-03-31	$48,944	532	-57.1%	Shares	Sole	2026-03-30
2022-12-31	$112,400	1,239	-96.9%	Shares	Defined	2026-03-30
2022-12-31	$997,920	11,000	-90.8%	Put	Sole	2026-03-30
2022-09-30	$3,065,483	40,330	+2459.0%	Shares	Defined	2022-11-03
2022-06-30	$133,218	1,576	+279.8%	Shares	Sole	2022-08-12
2022-03-31	$36,415	415	+2.5%	Shares	Defined	2022-05-16
2021-12-31	$35,423	405	-99.6%	Shares	Defined	2022-02-14
2021-09-30	$8,740,890	106,883	+94.7%	Shares	Sole	2021-11-09
2021-06-30	$5,008,071	54,889	-19.5%	Shares	Sole	2021-08-13
2021-03-31	$5,827,341	68,172	+380.8%	Shares	Sole	2021-05-13
2021-03-31	$10,257,600	120,000	+512.2%	Put	Sole	2021-05-13
2020-12-31	$1,338,922	14,179	-88.6%	Shares	Defined	2021-02-11
2020-12-31	$7,620,501	80,700	+120.5%	Call	Sole	2021-02-11
2020-12-31	$1,850,828	19,600	0.0%	Put	Sole	2021-02-11
2020-09-30	$3,182,736	36,600	-7.1%	Call	Sole	2020-11-12
2020-09-30	$10,769,213	123,841	+4493.5%	Shares	Defined	2020-11-12
2020-09-30	$1,704,416	19,600	-9.7%	Put	Sole	2020-11-12
2020-06-30	$235,468	2,696	-94.0%	Shares	Defined	2020-08-12
2020-06-30	$3,441,196	39,400	-27.4%	Call	Sole	2020-08-12
2020-06-30	$1,895,278	21,700	-74.9%	Put	Sole	2020-08-12
2020-03-31	$4,477,035	54,300	—	Call	Sole	2020-05-13
2020-03-31	$3,695,243	44,818	—	Shares	Defined	2020-05-13
2020-03-31	$7,123,680	86,400	—	Put	Sole	2020-05-13
No filing history on record for this holder in this stock.